Evaluation of bone regeneration with an injectable, in situ polymerizable pluronic® f127 hydrogel derivative combined with autologous mesenchymal stem cells in a goat tibia defect model

Tissue Engineering - Part A

Volumn 16, Issue 2, 2010, Pages 617-627

  Lippens, Evi ^a   Vertenten, Geert ^a   Gironès, Jordi ^a   Declercq, Heidi ^a   Saunders, Jimmy ^a   Luyten, Jan ^b   Duchateau, Luc ^a   Schacht, Etienne ^a   Vlaminck, Lieven ^a   Gasthuys, Frank ^a   Cornelissen, Maria ^a  

^a GHENT UNIVERSITY   (Belgium)

^b FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BONE; CELL CULTURE; DEFECTS; DEGRADATION; GELS; HYDROXYAPATITE; POLYMETHYL METHACRYLATES; STEM CELLS; THREE DIMENSIONAL;

BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE REGENERATION; BONE REPAIR; BONE SUBSTITUTES; CELL CARRIER; CELL SOURCES; CHEMICALLY MODIFIED; CONTROL DEFECTS; CONTROLLABLE DEGRADATION; DEFECT MODEL; HISTOLOGICAL EVALUATION; IN-SITU; IN-SITU FORMING; MESENCHYMAL STEM CELL; MICROCARRIERS; NO FORMATION; PLURONICS; POST-IMPLANTATION; REPAIR PROCESS; SHAPED DEFECTS; SOL-GEL TRANSITIONS; THREE-DIMENSIONAL NETWORKS; UNTREATED CONTROL;

HYDROGELS;

CAPRA HIRCUS;

POLOXAMER;

ANIMAL; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; BONE DEVELOPMENT; BONE REGENERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FOLLOW UP; GOAT; HYDROGEL; IMPLANT; INJECTION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; RADIOGRAPHY; TIBIA;

ANIMALS; BONE REGENERATION; FOLLOW-UP STUDIES; GOATS; HYDROGEL; IMPLANTS, EXPERIMENTAL; INJECTIONS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MODELS, ANIMAL; OSTEOGENESIS; POLOXAMER; TIBIA; TRANSPLANTATION, AUTOLOGOUS;

EID: 77049106676     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0418     Document Type: Conference Paper

References (30)

1. De Long, W.G., Jr., Einhorn, T.A., Koval, K., Mckee, M., Smith, W., Sanders, R., and Watson, T. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89, 649, 2007.
2. Finkemeier, C.G. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 84-A, 454, 2002.
3. Laurie, S.W., Kaban, L.B., Mulliken, J.B., and Murray, J.E. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 73, 933, 1984.
4. Wheeler, D.L., and Enneking, W.F. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res 435, 36, 2005.
5. Sopyan, I., Mel, M., Ramesh, S., and Khalid, K.A. Porous hydroxyapatite for artificial bone applications. Sci Technol Adv Mater 8, 116, 2007.
6. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
7. Tabata, Y. Biomaterial technology for tissue engineering applications. J R Soc Interface 6 Suppl 3, S311, 2009.
8. Vertenten, G., Lippens, E., Girones, J., Gorski, T., Declercq, H., Saunders, J., Van Den Broeck, W., Chiers, K., Duchateau, L., Schacht, E., Cornelissen, M., Gasthuys, F., and Vlaminck, L. Evaluation of an injectable, photopolymerizable, and three-dimensional scaffold based on methacrylate- endcapped poly(D,L-lactide-co-epsilon-caprolactone) combined with au-tologous mesenchymal stem cells in a goat tibial unicortical defect model. Tissue Eng Part A 15, 1501, 2009.
9. Vertenten, G., Vlaminck, L., Gorski, T., Schreurs, E., Van Den Broeck, W., Duchateau, L., Schacht, E., and Gasthuys, F. Evaluation of an injectable, photopolymerizable three-dimensional scaffold based on D,L-lactide and epsilon-caprolactone in a tibial goat model. J Mater Sci Mater Med 19, 2761, 2008.
10. Cancedda, R., Giannoni, P., and Mastrogiacomo, M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28, 4240, 2007.
11. Yang, Y., Rossi, F.M., and Putnins, E.E. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 28, 3110, 2007.
12. Dumortier, G., Grossiord, J.L., Agnely, F., and Chaumeil, J.C. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23, 2709, 2006.
13. Escobar-Chavez, J.J., Lopez-Cervantes, M., Naik, A., Kalia, Y.N., Quintanar-Guerrero, D., and Ganem-Quintanar, A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 9, 339, 2006.
14. Jeong, B., Kim, S.W., and Bae, Y.H. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 54, 37, 2002.
15. Klouda, L., and Mikos, A.G. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68, 34, 2008.
16. Swennen, I., Vermeersch, V., Hornof, M., Adriaens, E., Remon, J.-P., Urtti, A., and Schacht, E. In-situ crosslinkable thermo-sensitive hydrogels for drug delivery. J Control Release 116, e21, 2006.
17. Swennen, I. Thesis, Proefschrift voorgelegd tot het behalen van de graad: Doctor in de Wetenschappen, Groep Schei-kunde. Promotor E. Schacht. Ghent University, Belgium: Polymer Chemistry & Biomaterials Research Group, 2008.
18. Lippens, E., Swennen, I., Gironès, J., Declercq, H., Vertenten, G., Vlaminck, L., Gasthuys, F., Schacht, E., and Cornelissen, M. Modified Pluronic F127 in combination with cell-loaded CultiSpher-S carriers for bone tissue engineering. J Mater Sci Mater Med., submitted.
19. Dorea, H.C., Mclaughlin, R.M., Cantwell, H.D., Read, R., Armbrust, L., Pool, R., Roush, J.K., and Boyle, C. Evaluation of healing in feline femoral defects filled with cancellous autograft, cancellous allograft or Bioglass. Vet Comp Orthop Traumatol 18, 157, 2005.
20. Gustafson, C.J., Birgisson, A., Junker, J., Huss, F., Salemark, L., Johnson, H., and Kratz, G. Employing human keratino-cytes cultured on macroporous gelatin spheres to treat full thickness-wounds: an in vivo study on athymic rats. Burns 33, 726, 2007.
21. Huss, F.R., Junker, J.P., Johnson, H., and Kratz, G. Macro-porous gelatine spheres as culture substrate, transplantation vehicle, and biodegradable scaffold for guided regeneration of soft tissues. In vivo study in nude mice. J Plast Reconstr Aesthet Surg 60, 543, 2007.
22. Clavijo-Alvarez, J.A., Nguyen, V.T., Santiago, L.Y., Doctor, J.S., Lee, W.P., and Marra, K.G. Comparison of biodegradable conduits within aged rat sciatic nerve defects. Plast Reconstr Surg 119, 1839, 2007.
23. Woodard, J.R., Hilldore, A.J., Lan, S.K., Park, C.J., Morgan, A.W., Eurell, J.A., Clark, S.G., Wheeler, M.B., Jamison, R.D., and Wagoner Johnson, A.J. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials 28, 45, 2007.
24. Matsumoto, T., Okazaki, M., Nakahira, A., Sasaki, J., Egusa, H., and Sohmura, T. Modification of apatite materials for bone tissue engineering and drug delivery carriers. Curr Med Chem 14, 2726, 2007.
25. Fischer, E.M., Layrolle, P., Van Blitterswijk, C.A., and De Bruijn, J.D. Bone formation by mesenchymal progenitor cells cultured on dense and microporous hydroxyapatite particles. Tissue Eng 9, 1179, 2003.
26. Baroli, B. From natural bone grafts to tissue engineering therapeutics: brainstorming on pharmaceutical formulative requirements and challenges. J Pharm Sci 98, 1317, 2009.
27. Lee, O.K., Coathup, M.J., Goodship, A.E., and Blunn, G.W. Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats. Tissue Eng 11, 1727, 2005.
28. Mastrogiacomo, M., Scaglione, S., Martinetti, R., Dolcini, L., Beltrame, F., Cancedda, R., and Quarto, R. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 27, 3230, 2006.
29. Pearce, A.I., Richards, R.G., Milz, S., Schneider, E., and Pearce, S.G. Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 13, 1, 2007.
30. Hollinger, J.O., and Kleinschmidt, J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1, 60, 1990.